Home › Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A
 

Keywords :   


Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A

2013-02-06 10:00:00| drugdiscoveryonline Home Page

Seattle Genetics, Inc. recently announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas

Tags: phase seattle trials genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »